Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diabetes and Vascular Disease Research is Scopus-indexed (Q1, CiteScore 5.8), WoS SCIE, DOAJ. Published by SAGE Publications Ltd.
Checked against the index lists dated .
ISSN 1479-1641Verify ISSN ↗1752-8984Verify ISSN ↗
Publisher: SAGE Publications Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cardiology and Cardiovascular Medicine | 97 / 409 | 76th | Q1 |
| Internal Medicine | 51 / 179 | 71st | Q2 |
| Endocrinology, Diabetes and Metabolism | 85 / 250 | 66th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 5.8.
Diabetes and Vascular Disease Research is Q1 in Cardiology and Cardiovascular Medicine (rank 97 of 409), Q2 in Internal Medicine (rank 51 of 179) and Q2 in Endocrinology, Diabetes and Metabolism (rank 85 of 250), by CiteScore 2025.
Diabetes and Vascular Disease Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.907, quartile Q2, with an H-index of 68.
The publisher lists an article processing charge of about US$2,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Diabetes and Vascular Disease Research is published by SAGE Publications Ltd. Its print ISSN is 1479-1641 and its online ISSN is 1752-8984.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Diabetes and Vascular Disease Research has an h-index of 77 and a 2-year mean of 2.48 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #93 of 398 Scopus journals in Cardiology and Cardiovascular Medicine.
Diabetes and Vascular Disease Research published 25 papers in 2025; its busiest recent year was 2017 with 83. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023–2026), authors are most often from China (34.2%), United States (10.9%) and United Kingdom (5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.